|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 487/04 |
| (11) | Number of the document | 2173751 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08770791.5 |
| Date of filing the European patent application | 2008-06-12 | |
| (97) | Date of publication of the European application | 2010-04-14 |
| (45) | Date of publication and mention of the grant of the patent | 2013-11-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/066658 |
| Date | 2008-06-12 |
| (87) | Number | WO 2008/157207 |
| Date | 2008-12-24 |
| (30) | Number | Date | Country code |
| 943695 P | 2007-06-13 | US |
| (72) |
RODGERS, James D., US
ARVANITIS, Argyrios G., US
SHI, Jack Guoen, US
|
| (73) |
Incyte Corporation,
Experimental Station Route 141 & Henry Clay Road, Building E336, Wilmington, DE 19880,
US
|
| (54) | METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-LH-PYRAZOL-L-YL)-3- CYCLOPENTYLPROPANENITRILE |
| METABOLITES OF THE JANUS KINASE INHIBITOR (R)-3-(4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)-LH-PYRAZOL-L-YL)-3- CYCLOPENTYLPROPANENITRILE |